Club Phase 1 to hold it’s next meeting in Paris on 22-Mar-2016

ClubPhase1Club Phase 1, the AHPPI’s French sister human pharmacology organisation, will be holding it’s next meeting in Paris on 22 March.

The draft outline of the programme is included below:

  • Regulatory– Update on early phase clinical trial approval & on new EU regulation implementation – ANSM –Cecile Delval
  • Immunogenicity … How to deal with it? Nathalie Mace –Sanofi
  • Prediction of patient placebo response: from myth to reality. Impact on Proof of
  • Concept clinical trials. Alvaro Pereira -Tools4Patients
  • Use of modelling & simulation approaches in Clinical Development Speaker to be confirmed
  • Definition of ”adversity” in toxicologic pathology – Results of the ESTP expert workshop – Practical considerations for NOAEL definition and first into human studies Xavier Palazzi- Sanofi
  • Drug Drug Interactions & drug transporters: what’s new? Professor Jean Michel Scherrmann– Université Paris Descartes
  • Translational medicine from animal to human : oncology models Patricia Vrignaud –Institut Gustave Roussy
  • Translational medicine from animal to human : panic disorders Philippe Danjou – Biotrial Neurosciences

Use the following links to download the full draft Flyer and Registration Form.

This entry was posted in Other News and tagged . Bookmark the permalink.

Comments are closed.